Kosuke Shimizu

2.5k total citations
89 papers, 1.9k citations indexed

About

Kosuke Shimizu is a scholar working on Molecular Biology, Biomaterials and Cancer Research. According to data from OpenAlex, Kosuke Shimizu has authored 89 papers receiving a total of 1.9k indexed citations (citations by other indexed papers that have themselves been cited), including 43 papers in Molecular Biology, 17 papers in Biomaterials and 12 papers in Cancer Research. Recurrent topics in Kosuke Shimizu's work include Nanoparticle-Based Drug Delivery (17 papers), RNA Interference and Gene Delivery (16 papers) and Glycosylation and Glycoproteins Research (7 papers). Kosuke Shimizu is often cited by papers focused on Nanoparticle-Based Drug Delivery (17 papers), RNA Interference and Gene Delivery (16 papers) and Glycosylation and Glycoproteins Research (7 papers). Kosuke Shimizu collaborates with scholars based in Japan, Thailand and United Kingdom. Kosuke Shimizu's co-authors include Naoto Oku, Tomohiro Asai, Tatsuya Fukuta, Hiroyuki Koide, Takayuki Ishii, Tetsuo Minamino, Hideo Tsukada, Akihiko Sato, Noriyuki Maeda and Yasufumi Katanasaka and has published in prestigious journals such as Advanced Materials, PLoS ONE and Chemical Communications.

In The Last Decade

Kosuke Shimizu

86 papers receiving 1.8k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kosuke Shimizu Japan 27 982 585 386 244 184 89 1.9k
Tatsuya Fukuta Japan 20 555 0.6× 357 0.6× 256 0.7× 244 1.0× 76 0.4× 67 1.2k
Ye Xu China 32 1.3k 1.3× 253 0.4× 249 0.6× 189 0.8× 282 1.5× 77 2.5k
Zhonglian Cao China 26 934 1.0× 373 0.6× 549 1.4× 103 0.4× 191 1.0× 53 2.1k
Linwei Lu China 20 738 0.8× 555 0.9× 528 1.4× 58 0.2× 111 0.6× 42 1.4k
Juliana H. Azambuja Brazil 27 791 0.8× 180 0.3× 227 0.6× 114 0.5× 291 1.6× 60 1.7k
Li Fan China 24 748 0.8× 601 1.0× 463 1.2× 56 0.2× 121 0.7× 57 1.8k
Jianping Zhou China 29 907 0.9× 801 1.4× 674 1.7× 48 0.2× 212 1.2× 62 2.2k
Huae Xu China 27 918 0.9× 558 1.0× 623 1.6× 49 0.2× 200 1.1× 70 2.1k
Shyam S. Bansal United States 23 895 0.9× 246 0.4× 260 0.7× 56 0.2× 112 0.6× 56 2.3k
Shaofeng Duan China 27 792 0.8× 338 0.6× 488 1.3× 36 0.1× 159 0.9× 84 1.9k

Countries citing papers authored by Kosuke Shimizu

Since Specialization
Citations

This map shows the geographic impact of Kosuke Shimizu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kosuke Shimizu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kosuke Shimizu more than expected).

Fields of papers citing papers by Kosuke Shimizu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kosuke Shimizu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kosuke Shimizu. The network helps show where Kosuke Shimizu may publish in the future.

Co-authorship network of co-authors of Kosuke Shimizu

This figure shows the co-authorship network connecting the top 25 collaborators of Kosuke Shimizu. A scholar is included among the top collaborators of Kosuke Shimizu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kosuke Shimizu. Kosuke Shimizu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Begum, Firoza, Md. Maniruzzaman, Kosuke Shimizu, et al.. (2025). Enhancing Galantamine Distribution in Rat Brain Using Microplasma-Assisted Nose-to-Brain Drug Delivery. International Journal of Molecular Sciences. 26(4). 1710–1710.
2.
Tokunaga, T, M. Nishioka, Keita Kobayashi, et al.. (2025). Diagnostic Performance of the Novel Biomarker S2,3PSA Density for Prostate Biopsy Optimization in Prostate Imaging Reporting and Data System 3–5 Lesions. The Prostate. 86(2). 262–271. 2 indexed citations
3.
Shimizu, Kosuke. (2025). Treatment of Experimental Autoimmune Encephalomyelitis with Lipid Nanoparticles Loaded with siRNA Targeting Neogenin. Biological and Pharmaceutical Bulletin. 48(11). 1687–1693.
4.
5.
Kawasaki, Hideya, Takahiko Hariyama, Isao Kosugi, et al.. (2024). Human induced pluripotent stem cells are resistant to human cytomegalovirus infection primarily at the attachment level due to the reduced expression of cell-surface heparan sulfate. Journal of Virology. 98(3). e0127823–e0127823. 2 indexed citations
6.
Kimura, Yûki, et al.. (2021). Inhibition of cryoaggregation of phospholipid liposomes by an Arabidopsis intrinsically disordered dehydrin and its K-segment. Colloids and Surfaces B Biointerfaces. 211. 112286–112286. 6 indexed citations
7.
Hoshi, Yoko, Yukari Tanikawa, Eiji Okada, et al.. (2019). In situ estimation of optical properties of rat and monkey brains using femtosecond time-resolved measurements. Scientific Reports. 9(1). 9165–9165. 15 indexed citations
8.
Fukuta, Tatsuya, Tomohiro Asai, Takayuki Ishii, et al.. (2016). Non-invasive evaluation of neuroprotective drug candidates for cerebral infarction by PET imaging of mitochondrial complex-I activity. Scientific Reports. 6(1). 30127–30127. 14 indexed citations
9.
Kimura, Junko, Kosuke Shimizu, Jiro Takito, et al.. (2015). Upregulatory Effects of Nobiletin, a Citrus Flavonoid with Anti-dementia Activity, on the Gene Expression of mAChR, ChAT, and CBP. 2(1). e12–e14. 4 indexed citations
10.
Minami, Akira, Tadamune Otsubo, Kiyoshi Ikeda, et al.. (2014). Visualization of Sialidase Activity in Mammalian Tissues and Cancer Detection with a Novel Fluorescent Sialidase Substrate. PLoS ONE. 9(1). e81941–e81941. 39 indexed citations
11.
Ishii, Takayuki, Tomohiro Asai, Tatsuya Fukuta, et al.. (2012). A single injection of liposomal asialo-erythropoietin improves motor function deficit caused by cerebral ischemia/reperfusion. International Journal of Pharmaceutics. 439(1-2). 269–274. 33 indexed citations
12.
Ishii, Takayuki, Tatsuya Fukuta, Kosuke Shimizu, et al.. (2012). Nanoparticles accumulate in ischemic core and penumbra region even when cerebral perfusion is reduced. Biochemical and Biophysical Research Communications. 430(4). 1201–1205. 30 indexed citations
13.
Asai, Tomohiro, Hirokazu Shigematsu, Kosuke Shimizu, et al.. (2011). Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer. Journal of Controlled Release. 160(2). 274–280. 43 indexed citations
14.
Kenjo, Eriya, Tomohiro Asai, Atsushi Tsuruta, et al.. (2011). RGD-based active targeting of novel polycation liposomes bearing siRNA for cancer treatment. Journal of Controlled Release. 160(2). 177–181. 69 indexed citations
15.
Asakawa, Tomohiro, Makoto Inai, Hiroyuki Koide, et al.. (2011). PET imaging of nobiletin based on a practical total synthesis. Chemical Communications. 47(10). 2868–2868. 37 indexed citations
16.
Oku, Naoto, Takeo Urakami, Kentaro Hatanaka, et al.. (2010). PET imaging of brain cancer with positron emitter-labeled liposomes. International Journal of Pharmaceutics. 403(1-2). 170–177. 45 indexed citations
17.
Yoshida, Atsushi, Kouki Murakami, Takashi Suzuki, et al.. (2010). Concise synthesis of catechin probes enabling analysis and imaging of EGCg. Chemical Communications. 47(6). 1794–1796. 20 indexed citations
18.
Asai, Tomohiro, et al.. (2009). A novel DDS strategy, “dual-targeting”, and its application for antineovascular therapy. Cancer Letters. 287(2). 165–171. 45 indexed citations
19.
Asai, Tomohiro, Noriyuki Maeda, Kentaro Hatanaka, et al.. (2008). Antineovascular therapy with angiogenic vessel‐targeted polyethyleneglycol‐shielded liposomal DPP–CNDAC. Cancer Science. 99(5). 1029–1033. 18 indexed citations
20.
Shimizu, Kosuke, Tomohiro Asai, & Naoto Oku. (2005). Antineovascular therapy, a novel antiangiogenic approach. Expert Opinion on Therapeutic Targets. 9(1). 63–76. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tatsuya Fukuta Breakdown of academic impact, for papers by Ye Xu Breakdown of academic impact, for papers by Zhonglian Cao Breakdown of academic impact, for papers by Linwei Lu Breakdown of academic impact, for papers by Juliana H. Azambuja Breakdown of academic impact, for papers by Li Fan Breakdown of academic impact, for papers by Jianping Zhou Breakdown of academic impact, for papers by Huae Xu Breakdown of academic impact, for papers by Shyam S. Bansal Breakdown of academic impact, for papers by Shaofeng Duan
Rankless by CCL
2026